| Document Date: 2009-05-21 12:27:13
Open Document File Size: 137,37 KBShare Result on Facebook
City LENEXA / / Company Cleveland Clinic Journal / Internal Medicine / VasoGenix Pharmaceuticals / Ronald Trahan Associates Inc. / / Continent America / / Event Employment Change / / Facility Case Western Reserve University / Cleveland Clinic Lerner College of Medicine / Cleveland Clinic / / IndustryTerm bio-pharmaceutical / treatment for heart failure / / MedicalCondition disease / renal and respiratory diseases / heart failure / / MedicalTreatment heart transplant / / Organization Department of Medicine / American Board of Internal Medicine / Case Western Reserve University / Cleveland Clinic Lerner College of Medicine / / Person G. Lee Southard / James Young / / / Position professor / Chairman of the Division / Chairman and CEO / heart failure/heart transplant cardiologist / Private / member of the board / / ProvinceOrState Kansas / / PublishedMedium The Canadian Journal / / Technology Transplantation / /
SocialTag |
News Release FOR IMMEDIATE RELEASE Contact: Ronald C. Trahan, APR, Ronald Trahan Associates Inc., ([removed], x108 VasoGenix Pharmaceuticals elects Cleveland Clinic’s James Young, M.D., to its board of dir